Paula  Green net worth and biography

Paula Green Biography and Net Worth

Paula Green is an experienced human resources executive with a track record of developing and delivering high-impact people strategies, solutions, processes and tools that support leadership competencies to empower a high performing organization. Prior to Twist Bioscience, she served as Vice President, Head of Human Resources at QIAGEN, where she oversaw 50 human resources professionals supporting 4,000 employees through mergers and acquisitions, restructurings and other pivotal corporate transactions. She was the human resources manager for Operon Technologies (acquired by QIAGEN) where her responsibilities included creating strategy, overseeing benefits for all employees, and delivering training, recruitment and retention programs.  She also worked as a Human Resources Consultant for the Federal Home Loan Bank of San Francisco. Paula holds a BS in Organizational Behavior from the University of San Francisco.

What is Paula Green's net worth?

The estimated net worth of Paula Green is at least $3.14 million as of March 6th, 2024. Ms. Green owns 92,850 shares of Twist Bioscience stock worth more than $3,141,116 as of March 18th. This net worth evaluation does not reflect any other assets that Ms. Green may own. Additionally, Ms. Green receives an annual salary of $618,480.00 as SVP at Twist Bioscience. Learn More about Paula Green's net worth.

How old is Paula Green?

Ms. Green is currently 56 years old. There are 6 older executives and no younger executives at Twist Bioscience. The oldest executive at Twist Bioscience is Dr. William Charles Banyai Ph.D., Senior VP of Advanced Development, GM of Data Storage & Director, who is 69 years old. Learn More on Paula Green's age.

What is Paula Green's salary?

As the SVP of Twist Bioscience Co., Ms. Green earns $618,480.00 per year. There are 3 executives that earn more than Ms. Green. The highest earning executive at Twist Bioscience is Dr. Emily Marine Leproust Ph.D., Co-Founder, Chairman & CEO, who commands a salary of $1,370,000.00 per year. Learn More on Paula Green's salary.

How do I contact Paula Green?

The corporate mailing address for Ms. Green and other Twist Bioscience executives is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. Twist Bioscience can also be reached via phone at (800) 719-0671 and via email at [email protected]. Learn More on Paula Green's contact information.

Has Paula Green been buying or selling shares of Twist Bioscience?

Within the last three months, Paula Green has sold $22,458.00 in Twist Bioscience stock. Most recently, Paula Green sold 600 shares of the business's stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $37.43, for a transaction totalling $22,458.00. Following the completion of the sale, the senior vice president now directly owns 92,850 shares of the company's stock, valued at $3,475,375.50. Learn More on Paula Green's trading history.

Who are Twist Bioscience's active insiders?

Twist Bioscience's insider roster includes William Banyai (Insider), Robert Chess (Director), Keith Crandell (Director), Mark Daniels (Insider), Patrick Finn (Insider), Paula Green (SVP), Jan Johannessen (Director), Emily Leproust (CEO), James Thorburn (CFO), and Patrick Weiss (COO). Learn More on Twist Bioscience's active insiders.

Are insiders buying or selling shares of Twist Bioscience?

In the last year, Twist Bioscience insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $132,000.00. In the last year, insiders at the sold shares 6 times. They sold a total of 6,743 shares worth more than $242,057.80. The most recent insider tranaction occured on March, 14th when insider Dennis Cho sold 93 shares worth more than $3,217.80. Insiders at Twist Bioscience own 3.9% of the company. Learn More about insider trades at Twist Bioscience.

Information on this page was last updated on 3/14/2024.

Paula Green Insider Trading History at Twist Bioscience

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2024Sell600$37.43$22,458.0092,850View SEC Filing Icon  
9/16/2022Sell8,514$37.43$318,679.0214,199View SEC Filing Icon  
6/15/2022Sell10,067$30.47$306,741.4914,727View SEC Filing Icon  
6/14/2021Sell14,161$113.84$1,612,088.2420,095View SEC Filing Icon  
5/21/2021Sell490$98.64$48,333.6020,885View SEC Filing Icon  
4/26/2021Sell264$135.60$35,798.4021,409View SEC Filing Icon  
1/25/2021Sell246$193.00$47,478.0022,496View SEC Filing Icon  
12/15/2020Sell4,634$139.73$647,508.8222,804View SEC Filing Icon  
9/16/2020Sell26,988$63.37$1,710,229.5646,458View SEC Filing Icon  
6/15/2020Sell16,833$38.00$639,654.0039,448View SEC Filing Icon  
See Full Table

Paula Green Buying and Selling Activity at Twist Bioscience

This chart shows Paula Green's buying and selling at Twist Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Twist Bioscience Company Overview

Twist Bioscience logo
Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $33.83
Low: $32.87
High: $34.52

50 Day Range

MA: $36.65
Low: $32.28
High: $41.50

2 Week Range

Now: $33.83
Low: $11.46
High: $43.21

Volume

634,175 shs

Average Volume

995,473 shs

Market Capitalization

$1.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.64